Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?

de Joode AA, Sanders JS, Rutgers A, Stegeman CA.

Nephrol Dial Transplant. 2015 Jan 20. pii: gfu397. [Epub ahead of print] Review.

PMID:
25609739
[PubMed - as supplied by publisher]
2.

Pathogenesis of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis and Potential Targets for Biologic Treatment.

Sanders JS, Abdulahad WH, Stegeman CA, Kallenberg CG.

Nephron Clin Pract. 2014 Nov 11. [Epub ahead of print]

PMID:
25401277
[PubMed - as supplied by publisher]
3.

T cells in vascular inflammatory diseases.

Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH.

Front Immunol. 2014 Oct 14;5:504. doi: 10.3389/fimmu.2014.00504. eCollection 2014. Review.

PMID:
25352848
[PubMed]
Free PMC Article
4.

Accurate and fast diagnostic algorithm for febrile urinary tract infections in humans.

Gieteling E, van de Leur JJ, Stegeman CA, Groeneveld PH.

Neth J Med. 2014 Sep;72(7):356-62.

PMID:
25178769
[PubMed - in process]
Free Article
5.

Characterization of urinary CD4⁺ and CD8⁺ T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection.

van Doesum WB, Abdulahad WH, van Dijk MC, Dolff S, van Son WJ, Stegeman CA, Sanders JS.

Transpl Infect Dis. 2014 Oct;16(5):733-43. doi: 10.1111/tid.12273. Epub 2014 Aug 5.

PMID:
25092256
[PubMed - in process]
6.

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

de Souza AW, Abdulahad WH, Sosicka P, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG.

Clin Exp Immunol. 2014 Nov;178(2):270-8. doi: 10.1111/cei.12422.

PMID:
25052363
[PubMed - indexed for MEDLINE]
7.

Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Iklé D, Villarreal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheumatol. 2014 Nov;66(11):3151-9. doi: 10.1002/art.38788.

PMID:
25047592
[PubMed - in process]
8.

The renal angiopoietin/Tie2 system in lethal human sepsis.

Aslan A, Jongman RM, Moser J, Stegeman CA, van Goor H, Diepstra A, van den Heuvel MC, Heeringa P, Molema G, Zijlstra JG, van Meurs M.

Crit Care. 2014 Mar 31;18(2):423. doi: 10.1186/cc13806. No abstract available.

PMID:
24976393
[PubMed - in process]
Free PMC Article
9.

Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis.

Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR; European Vasculitis Study Group.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1571-6. doi: 10.2215/CJN.00100114. Epub 2014 Jun 26.

PMID:
24970876
[PubMed - in process]
10.

Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177.

Hu N, Mora-Jensen H, Theilgaard-Mönch K, Doornbos-van der Meer B, Huitema MG, Stegeman CA, Heeringa P, Kallenberg CG, Westra J.

PLoS One. 2014 Jun 13;9(6):e99671. doi: 10.1371/journal.pone.0099671. eCollection 2014.

PMID:
24926686
[PubMed - in process]
Free PMC Article
11.

In reply to 'rituximab and B-cell return in ANCA-associated vasculitis'.

Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P.

Am J Kidney Dis. 2014 Jun;63(6):1066-7. doi: 10.1053/j.ajkd.2014.02.028. No abstract available.

PMID:
24856617
[PubMed - indexed for MEDLINE]
12.

A false-positive antineutrophil cytoplasmic antibody proteinase 3 test in a patient with pulmonary-renal syndrome.

Agterhuis DE, Mulder AH, Roozendaal C, Stegeman CA, Laverman GD.

J Rheumatol. 2014 May;41(5):1031-3. doi: 10.3899/jrheum.131205. No abstract available.

PMID:
24788467
[PubMed - in process]
13.

Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.

Souza AW, de Leeuw K, van Timmeren MM, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG.

PLoS One. 2014 Apr 28;9(4):e96067. doi: 10.1371/journal.pone.0096067. eCollection 2014.

PMID:
24776932
[PubMed - in process]
Free PMC Article
14.

Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.

Lepse N, Abdulahad WH, Rutgers A, Kallenberg CG, Stegeman CA, Heeringa P.

Rheumatology (Oxford). 2014 Sep;53(9):1683-92. doi: 10.1093/rheumatology/keu149. Epub 2014 Apr 10.

PMID:
24729403
[PubMed - indexed for MEDLINE]
15.

Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.

de Joode AA, Sanders JS, Smid WM, Stegeman CA.

J Clin Apher. 2014 Oct;29(5):266-72. doi: 10.1002/jca.21318. Epub 2014 Feb 4.

PMID:
24497412
[PubMed - in process]
16.

Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.

de Joode AA, Roozendaal C, van der Leij MJ, Bungener LB, Sanders JS, Stegeman CA.

Eur J Intern Med. 2014 Feb;25(2):182-6. doi: 10.1016/j.ejim.2013.11.011. Epub 2013 Dec 19.

PMID:
24361117
[PubMed - indexed for MEDLINE]
17.

Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life?

Tuin J, Sanders JS, Buhl BM, van Beek AP, Stegeman CA.

Arthritis Res Ther. 2013;15(5):R117.

PMID:
24028544
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

de Souza A, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CG.

Arthritis Res Ther. 2013;15(5):R104.

PMID:
24007972
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.

N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.

PMID:
23902481
[PubMed - indexed for MEDLINE]
Free Article
20.

Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis.

de Joode AA, Sanders JS, Stegeman CA.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1709-17. doi: 10.2215/CJN.01020113. Epub 2013 Jul 11.

PMID:
23846462
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk